Repare Therapeutics Stock Probability of Future Stock Price Finishing Over 16.85
| RPTX Stock | USD 3.32 0.17 5.40% |
Repare |
Repare Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Repare Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Repare Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Repare Therapeutics had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 51.13 M. Net Loss for the year was (93.8 M) with profit before overhead, payroll, taxes, and interest of 15.11 M. | |
| Repare Therapeutics currently holds about 282.09 M in cash with (127.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.73, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Repare Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Over 84.0% of the company shares are owned by institutional investors |
Repare Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Repare Stock often depends not only on the future outlook of the current and potential Repare Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Repare Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 42.1 M | |
| Cash And Short Term Investments | 223.6 M |
Repare Therapeutics Technical Analysis
Repare Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Repare Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Repare Therapeutics. In general, you should focus on analyzing Repare Stock price patterns and their correlations with different microeconomic environments and drivers.
Repare Therapeutics Predictive Forecast Models
Repare Therapeutics' time-series forecasting models is one of many Repare Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Repare Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Repare Therapeutics
Checking the ongoing alerts about Repare Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Repare Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Repare Therapeutics had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 51.13 M. Net Loss for the year was (93.8 M) with profit before overhead, payroll, taxes, and interest of 15.11 M. | |
| Repare Therapeutics currently holds about 282.09 M in cash with (127.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.73, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Repare Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Over 84.0% of the company shares are owned by institutional investors |
Additional Tools for Repare Stock Analysis
When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.